1. Meeting and attendance
(1) The convening of the meeting
1. Meeting time: August 18, 2021
2. Meeting place: company meeting room
3. Meeting method: on-site and communication
4. Time and method of issuing notice of board meeting: August 6, 2021 by mail
5. Moderator of the meeting: Chairman Wang Xueliang
6. Conference attendees (if any): supervisors, senior management
7. Explanation of the legality, compliance and constitutionality of the convening:
The convening and convening procedures of this meeting, the qualifications of attending the meeting and the qualifications of the convener, and the voting procedures of the meeting are in compliance with the "Company Law of the People's Republic of China", "Articles of Association" and relevant laws, regulations and regulations, and the resolutions made are legal and valid.

(2) Meeting attendance
7 directors should be present at the meeting, and 7 directors should be present and authorized to attend.
Director Sun Pengjun was absent due to personal reasons and entrusted Director Wang Xueliang to vote on his behalf (if any).

2. Review of the proposal
(1) The proposal of "The Company's 2021 Semi-annual Report" was considered and passed
1. The content of the proposal:
The report has been disclosed in the "2021 Semi-annual Report" (Announcement No.: 2021-026) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn).
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
(2) The proposal of "Special Report on the Deposit and Actual Use of Funds Raised in the First Half of 2021" was considered and passed
1. The content of the proposal:
The report has been disclosed in the "Special Report on the Deposit and Actual Use of Funds Raised in the First Half of 2021" (Announcement No.: 2021-027) published on the Information Disclosure Platform of the National SME Share Transfer System (www.neeq.com.cn) .
2. The voting results of the proposal: 7 votes in favor; 0 votes against; 0 abstentions.
3. Avoid voting:
This proposal does not involve related matters, and there is no situation in which voting should be avoided.
4. Submitted to the general meeting of shareholders to vote:
This proposal does not need to be submitted to the general meeting of shareholders for deliberation.
3. List of available documents
Resolutions of the 16th meeting of the second board of directors of Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.

Shanghai Yan'an Pharmaceutical Yangpu Co., Ltd.
Board of Directors
August 19, 2021